FIELD: immunobiotechnology. SUBSTANCE: method involves infection of cell culture with virus followed by its reproduction and inactivation, isolation, purification and sorption on viral antigen adjuvant. Cell culture is immobilized on collagen microcarrier at particle diameter 160-250 mcm and infected with tick-borne encephalitis virus at dose 5-30 LD50/cell. Antigen is isolated by sedimentation treatment at separation factor 7000-12000. For infection expediently to use diploid cells of human fetal lung culture or disaggregated culture of chicken embryo fibroblasts. EFFECT: improved method of vaccine preparing. 3 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING VACCINE OF TICK- BORNE ENCEPHALITIS | 2001 |
|
RU2203089C2 |
METHOD FOR PRODUCING TICK-BORNE ENCEPHALITIS VIRUS VACCINE | 2017 |
|
RU2678431C1 |
METHOD OF PRODUCING FOUR-COMPONENT LIVE CULTURE VACCINE AGAINST MEASLES, VARICELLA, MUMPS, AND RUBELLA | 2019 |
|
RU2717769C1 |
VACCINE STRAIN OF MEASLES VIRUS "ORLOV-D" AND METHOD OF PREPARING VACCINE AGAINST MEASLES | 1999 |
|
RU2173344C2 |
METHOD OF PREPARING VACCINE AGAINST HEPATITIS A | 1989 |
|
SU1672635A1 |
AGENT SHOWING EFFECT WITH RESPECT TO INFECTIOUS AGENTS | 1994 |
|
RU2092177C1 |
METHOD OF OBTAINING LIVE CULTURAL ATTENUATED VACCINE FOR THE PREVENTION OF VARICELLA | 2016 |
|
RU2637093C1 |
METHOD OF PHYLOVIRUS SUSPENSION CULTURING IN CELL CULTURE ON MICROCARRIERS | 1993 |
|
RU2076905C1 |
METHOD OF PREPARING THE SOLUBLE ANTIGEN-BASE VACCINE FOR TICK-BORNE ENCEPHALITIS CONTROL | 1994 |
|
RU2084242C1 |
DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
Authors
Dates
1997-06-27—Published
1993-07-19—Filed